The role of atypical microorganisms in chronic oropharyngeal phlogosis

European Journal of Inflammation

Volumn 8, Issue 3, 2010, Pages 201-210

  Neri, Giampiero ^a   Citraro, L ^a   Martinotti, S ^a   Toniato, E ^a   Castriotta, A ^a   De Rosa, M ^a   Filograna Pignatelli, G ^a   Croce, A ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Chlamydia trachomatis; Chronic pharyngitis; Mollicutes; PCR

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIAL URETHRITIS; CHRONIC DISEASE; CHRONIC OROPHARYNGEAL PHLOGOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA HOMINIS INFECTION; PHARYNGITIS; UREAPLASMA INFECTION;

EID: 80053483362     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727X1000800310     Document Type: Article

References (40)

1. Schappert SM, Burt CW. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 2001-02. Vital Health Stat 13 2006; 159:1-66.
2. Thompson LR, Wenig BM, Kornblut AD. Pharyngitis. In: Bailey BR (ed) Head and neck surgery-otolaryngology, 3rd ed. Lippincott Williams & Wilkins, Philadelphia 2001; p. 544.
3. McIsaac WJ, Goel V, To T, Low DE. The validity of a sore throat score in family practice. CMAJ 2000; 163:811-5.
4. Papp JR, Ahrens K, Phillips C, Kent CK, Philip S, Klausner JD. The use and performance of oral-throat rinses to detect pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections. Diagn Microbiol Infect Dis 2007; 59:259-64. (Pubitemid 350016695)
5. Stamm WE, Holmes KK, Mardh P-A, et al., Eds. Sexually transmitted diseases 2nd ed. McGraw-Hill, New York 1990:181-194.
6. Salomon AW, Peeling RW, Foster A, Mabey David CW. Diagnosis and assessment of Trachoma. Clin Microbiol Rev 2004; 17:982-1011. (Pubitemid 39372527)
7. Wataru Ishii. Reactive arthritis due to asymptomatic infection of Chlamydia trachomatis. Intern Med 2005; 44:509-10.
8. Brunham RC, Maclean IW, Binns, Peeling RW. Chlamydia trachomatis: its role in tubal infertility. J infect Dis 1985; 152:1275-82. (Pubitemid 16215606)
9. Hosseinzadeh S, Pacey AA, Eley A. Chlamydia trachomatis-induced death of human spermatozoa is caused prymarily by lipopolysaccharide. J Med Microbiol 2003; 52:193-200. (Pubitemid 36324205)
10. Motrich RD, Cuffini C, Oberti JP, Maccioni M, Rivero VE. Chlamydia trachomatis occurrence and its impact on sperm quality in chronic prostatitis patients. J Infect 2006; 53:175-83. (Pubitemid 44249619)
11. Di Leo E, Aloia AM, Nettis E, Cardinale F, Foti C, Distaso M, Ferrannini A, Vacca A. Long-term tolerability of etoricoxib in patients with previous reactions to non-steroidal anti-inflammatory drugs. Int J Immunopathol Pharmacol 2009; 22:1131-4.
12. Chiba Y, Sato S, Misawa M. GGTI-2133, an inhibitor of geranylgeranyltransferase, inhibits infiltration of inflammatory cells into airways in mouse experimental asthma. Int J Immunopathol Pharmacol 2009; 22:929-35.
13. Waites KB, Katz B, Schelonka RL. Mycoplasmas and Ureaplasmas as neonatal pathogens. Clin Microbiol Rev 2005; 18:757-89. (Pubitemid 41504514)
14. Brunner H, Weidner W, Schiefer HG. Studies on the role of Ureaplasma urealyticum and Mycoplasma hominis in prostatitis. J Infect Dis 1983; 147:807-13. (Pubitemid 13094230)
15. Ness RB, Soper DE, Richter HE, et al. Chlamydia antibodies, chlamydia heat shock protein, and adverse sequelae after pelvic inflammatory disease: the PID Evaluation and Clinical Health (PEACH) Study. Sex Transm Dis 2008; 35:129-35. (Pubitemid 351158690)
16. Yip KH, Huang Y, Waye MM, Lau HY. Induction of nitric oxide synthases in primary human cultured mast cells by IgE and proinflammatory cytokines. Int Immunopharmacol 2008; 8:764-8.
17. D'Agosto G, Trento E, Nosotti L, et al. CD81 expression on CD19+ peripheral blood lymphocytes is associated with chronic HCV disease and increased risk for HCV infection: a putative role for inflammatory cytokines. J Biol Regul Homeost Agents 2009; 23:155-64.
18. Taylor-Robinson D, Furr PM. Genital mycoplasma infections. Wien Klin Wochenschr 1997; 109:578-83. (Pubitemid 27342853)
19. Komaroff AL, Aronson MD, Pass TM, Ervin CT, Branch WT Jr, Schachter J. Serologic evidence of chlamydial and mycoplasmal pharyngitis in adults. Science 1983; 222:927-9. (Pubitemid 14228278)
20. Ciprandi G, De Amici M, Tosca MA, Pistorio A, Marseglia GL. Sublingual immunotherapy affects specific antibody and TGF-β serum levels in patients with allergic rhinitis. Int J Immunopathol Pharmacol 2009; 22:1089-96.
21. Ciprandi G, Cirillo I, Pistorio A, Di Gioacchino M, Fenoglio D. Ebastine increases IFN-gamma production in patients with persistent allergic rhinitis. J Biol Regul Homeost Agents 2009; 23:31-36.
22. Huss H, Jungkind D, Amadio P, Rubenfeld I. Frequency of Chlamydia trachomatis as the cause of pharyngitis. J Clin Microbiol 1985; 22:858-60. (Pubitemid 16217803)
23. Mikamo H, Tamaya T, Tanaka K, Watanabe K. Prevalence and treatment of pharyngeal Chlamydia trachomatis infections. Jpn J Antibiot 2006; 59:35-40.
24. Noguchi Y. Pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections. Nippon Rinsho 2009; 67:173-6.
25. Mpiga P, Ravaoarinoro M. Chlamydia trachomatis persistence: an update. Microbiol Res 2006; 161:9-19. (Pubitemid 41773108)
26. Pichichero ME. Group A streptococcal tonsillopharyngitis: cost-effective diagnosis and treatment. Ann Emerg Med 1995; 25:390-403.
27. Morré SA, van Valkengoed IG, de Jong A, Boeke AJ, van Eijk JT, Meijer CJ, van den Brule AJ. Mailed, home-obtained urine specimens: a reliable screening approach for detecting asymptomatic Chlamydia trachomatis infections. J Clin Microbiol 1999; 37:976-80. (Pubitemid 29140600)
28. Jebakumar SP, Storey C, Lusher M, Nelson J, Goorney B, Haye KR. Value of screening for oropharyngeal Chlamydia trachomatis infection. J Clin Pathol. 1995; 48:658-61.
29. Li Q, Kobayashi M, Wakayama Y, et al. Effect of phytoncide from trees on human natural killer cell function. Int J Immunopathol Pharmacol 2009; 22:951-9.
30. Nishimura Y, Maeda M, Kumagai N, Hayashi H, Miura Y, Otsuki T. Decrease in phosphorylation of ERK following decreased expression of NK cell activating receptors in human NK cell line exposed to asbestos. Int J Immunopathol Pharmacol 2009; 22:879-88.
31. Papp JR, Ahrens K, Phillips C, Kent CK, Philip S, Klausner JD. The use and performance of oral-throat rinses to detect pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections. Diagn Microbiol Infect Dis 2007; 59:259-64. (Pubitemid 350016695)
32. Gerber MA, Ryan RW, Tilton RC, Watson JE. Role of Chlamydia trachomatis in acute pharyngitis in young adults. J Clin Microbiol 1984; 20:993-4. (Pubitemid 15207378)
33. Moulder JW. Comparative biology of intracellular parasitism. Microbiol Rev 1985; 49:298-337. (Pubitemid 15023299)
34. Peterson EM, De La Maza LM. Chlamydia parasitism: ultrastructural characterization of the interaction between the chlamydial cell envelope and the host cell. J Bacteriol 1988; 170:1389-92. (Pubitemid 18079075)
35. Dreses-Werringloer U, Padubrin I, Jürgens-Saathoff B, Hudson AP, Zeidler H, Köhler L. Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro. Antimicrob Agents Chemother 2000; 44:3288-97. (Pubitemid 33009485)
36. Sarlangue J, Castella C. Chlamydia infection in neonates and infants. Arch Pediatr 2005; 12:32-4
37. Di Bonito P, Grasso F, Mangino G, et al. Immunomodulatory activity of a plant extract containing human papillomavirus 16-E7 protein in human monocyte-derived dendritic cells. Int J Immunopathol Pharmacol 2009; 22:967-8.
38. Castellani ML, Kempuraj DJ, Salini V, et al. The latest interleukin: IL-33 the novel IL-1-family member is a potent mast cell activator. J Biol Regul Homeost Agents 2009; 23:11-14.
39. Wu S, Shen L, Liu G. Study on vertical transmission of Chlamydia trachomatis using PCR and DNA sequencing. Chin Med J (Engl) 1999; 112:396-9.
40. Dreses-Werringloer U, Padubrin I, Jürgens-Saathoff B, Hudson AP, Zeidler H, Köhler L. Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro. Antimicrob Agents Chemother 2000; 44:3288-97. (Pubitemid 33009485)